Oxymatrine-d3

Oxymatrine-d3 is the deuterium labeled Oxymatrine. Oxymatrine, an alkaloid from Sophora flavescens Alt. with anti-inflammatory, antifibrosis, and antitumor effects, inhibits the iNOS expression and TGF-β/Smad pathway. Oxymatrine inhibits bocavirus minute virus of canines (MVC) replication, reduces viral gene expression and decreases apoptosis induced by viral infection[1][2][3][4].

2714484-46-3

12352005

Apoptosis; Isotope-Labeled Compounds; TGF-beta/Smad

Apoptosis; Others; Stem Cell/Wnt; TGF-beta/Smad

COVID-19-anti-virus

Cancer; Infection; Inflammation/Immunology

O=C1CCC[C@]2([2H])[C@@]3([H])CCC[N+]4([O-])[C@@]3([H])[C@](CCC4)([H])C([2H])([2H])N21

C15H21D3N2O2

267.38

[1]Lu ML, et al. Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine. Phytother Res. 2016 Jul;30 (7) :1104-12.|[2]Wu C, et al. Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo. Mol Med Rep. 2015 Jun;11 (6) :4129-34.|[3]Wu XL, et al. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol. 2008 Apr 7;14 (13) :2100-5.|[4]Ding Y, et al. Oxymatrine Inhibits Bocavirus MVC Replication, Reduces Viral Gene Expression and Decreases Apoptosis Induced by Viral Infection. Virol Sin. 2019 Feb;34 (1) :78-87.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W750902/

Isotope-Labeled Compounds

No Development Reported